Patanjali Foods Limited has informed the Exchange regarding Outcome of Board Meeting held on May 15, 2025 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended on March 31, 2025.
PATANJALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Patanjali Foods approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with statutory auditor Chaturvedi & Shah LLP issuing an unmodified (clean) opinion. Standalone revenue from operations grew about 7.6% YoY to Rs. 34,156.97 crore, while profit after tax jumped roughly 70% to Rs. 1,301.34 crore (FY24: Rs. 765.15 crore), with EPS at Rs. 35.99 vs Rs. 21.14. The Board recommended a final dividend of Rs. 2 per share, taking total FY25 dividend to Rs. 10 per share (including the Rs. 8 interim dividend already paid). A new Home & Personal Care segment was added from November 1, 2024, following the Rs. 1,100 crore acquisition of the non-food business from related party Patanjali Ayurved Limited. Operating cash flow, however, fell sharply to Rs. 197.7 crore from Rs. 1,746.2 crore last year due to a large inventory build-up (inventories rose from Rs. 3,768 crore to Rs. 6,210 crore).
Strong earnings growth, a clean audit, and a healthy Rs. 10/share total dividend are positives for shareholders, but the sharp drop in operating cash flow, ballooning inventory, and a major contingent liability from an arbitration award (requiring issuance of ~1.87 crore shares to Ashav Advisory LLP, currently under challenge in Delhi High Court) are key risks to monitor.